1. Li P, Qi L W, Wen X D, et al. Methods for the elucidation of bioactive components and quality control of traditional Chinese medicines (in Chinese). Chin J Nat Med, 2007, 5: 1–9 [李萍, 齐炼文, 闻晓东, 等. 中药效应物质基础和质量控制研究的思路与方法. 中国天然药物, 2007, 5: 1–9].
2. Liu X M, Xiao P G. The modernization of traditional Chinese medicine is necessary during the development of Chinese medicine in the 21st century (in Chinese). 1997: 3 [刘新民, 肖培根. 中药现代化是21世纪中药发展的必然. 中国中医药学会博士学术研究会筹委会. 1997中医药博士论坛: 中医药现代研究与未来发展. 中国中医药学会博士学术研究会筹委会: 中华中医药学会糖尿病分会, 1997: 3].
3. Luo H M, Liu X W, Zhang F Z, et al. Analysis of projects funded by NSFC in field of efficacy material base of traditional Chinese medicine (in Chinese). Chin J Chin Mater Med, 2020, 45: 3233–3237 [罗浩铭, 刘学伟, 张凤珠, 等. 从国家自然科学基金资助项目浅析中药药效物质研究概况. 中国中药杂志, 2020, 45: 3233–3237].
4. Jiang N, Zhang Y X, Du G H. Novel ideas and methods of pharmacological and new drug research of traditional Chinese medicine (in Chinese). Chin J Pharm Toxicol, 2016, 30: 893–909 [蒋宁, 张永祥, 杜冠华. 新思路·新方法——中药药理学研究与中药新药研发. 中国药理学与毒理学杂志, 2016, 30: 893–909].
5. Wolfender J L, Nuzillard J M, van der Hooft J J J. Accelerating metabolite identification in natural product research: toward an ideal combination of liquid chromatography-high-resolution tandem mass spectrometry and NMR profiling, in silico databases, and chemometrics. Anal Chem, 2019, 91: 704-742.